📋 THERIVA BIOLOGICS, INC. (TOVX) - Financial Results
Filing Date: 2026-05-05
Accepted: 2026-05-05 16:35:32
Event Type: Financial Results
Event Details:
THERIVA BIOLOGICS, INC. (TOVX) Reports the reporting period Financial Results
THERIVA BIOLOGICS, INC. (TOVX) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 300
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 14431
targeting potential approval of the BLA prior to September 30, 2029
targeting potential BLA approval prior to September 30, 2029
📋 THERIVA BIOLOGICS, INC. (TOVX) - Financial Results
Filing Date: 2026-05-05
Accepted: 2026-05-05 16:35:32
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: